Display Settings:

Format

Send to:

Choose Destination
    Gan To Kagaku Ryoho. 2008 Jun;35(6):1013-6.

    [A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1].

    [Article in Japanese]

    Source

    Dept. of Gastroenterology, National Kyushu Cancer Center.

    Abstract

    The patient was a 70-year-old man with metastatic pancreatic cancer. After he received combination chemotherapy with gemcitabine and oral S-1 on day 1, he experienced severe general fatigue, anorexia and nausea. Then we changed the dose of gemcitabine from 1,000 mg/m(2) 2 to 500 mg/m(2) according to the criteria for an individual maximum repeatable dose (iMRD) determination method on day 8. His general condition recovered, and treatment schedule of gemcitabine with S-1 was continued sequentially at an outpatient clinic. His tumor marker levels, and the sizes of primary pancreatic tumor and liver metastatic lesions remarkably decreased. Partial response has been obtained for 7 months.

    PMID:
    18633236
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Sunmedia PierOnline

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk